(Date:1/6/2009)...ge, Md. An international group of scientists is l...eas to an increase in the number of harmful algal ...l blooms (HAB,s) occur, they taint seafood with to... and cause fish or mammal kills in coastal waters....ful Algae , scientists present a compilation of 21...
(Date:1/6/2009)... The January issue of the Journal of the America...focusing on everyday eating habits of consumers. R... meet the nutritional needs of preschool children ...diets of young adults. , Packing a Lunch for Pr...y 13 million children in the United States eat thr...
(Date:1/6/2009)...am, January 6, 2009 Elsevier, a leading global hea...e four finalists chosen in the Elsevier Grand Chal...type tools dealing with the ever-increasing amount...iergrandchallenge.com ). The semifinalist round w...itute of Technology in Boston and featured each of...
(Date:1/6/2009)...ochelle, NY, January 6, 2009Dedicated to the memor...man, who pioneered the fields of angiogenesis and ...blood supply and neoplastic disease, the newly rel...of Lymphatic Research and Biology includes a ser...one of the pre-eminent physician-scientists of his...
Breaking Biology News(10 mins):News from the January 2009 Journal of the American Dietetic Association 2Finalists announced in the Elsevier Grand Challenge 2Finalists announced in the Elsevier Grand Challenge 3Festschrift Issue honoring Judah Folkman, M.D. in Lymphatic Research and Biology 2Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 1049 1Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 1049 2Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 1049 3Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke 1049 4Active compounds found in Ganoderma lucidum fungus with potential to treat prostate cancer 8119 1Active compounds found in Ganoderma lucidum fungus with potential to treat prostate cancer 8119 2UQ health and medical researchers recognized in awards 8116 1UQ health and medical researchers recognized in awards 8116 2Fuel cells help make noisy hot generators a thing of the past 1557 1Fuel cells help make noisy hot generators a thing of the past 1557 2(Date:1/7/2009).... 7 Sangart, Inc., a privately hel...ch, development and,commercialization of oxygen-t...ructuring that includes the addition of four key l...n work force, primarily in the product manufacturi... burn rate and refocuses,Sangart,s business units...
(Date:1/7/2009)...RNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: ...al to the U.S. Food and Drug Administration ("FDA"...study (D-21) in depression patients treated with V...e study power and size following the FDA,s approva...specified in the study protocol, the company propo...
(Date:1/7/2009)...if., Jan. 7 Intradigm Corporation,...terference (RNAi) therapeutics, today,announced t...s Series B,financing. Astellas Venture Management...stor, Lilly Ventures, also participating. The add...nancing to $21.4 million. Intradigm will,use Ser...
(Date:1/7/2009)...., Jan. 7 News briefs concerning e...on from the Tampa Bay Partnership: , Drap..., The Charles Stark Draper Laboratory bought...recently where it plans to manufacture microchips ...0050 16th St. N., should be completed,in March 20...
Breaking Biology Technology:Sangart, Inc. Announces Key Executive Appointments and Company Restructuring 2Sangart, Inc. Announces Key Executive Appointments and Company Restructuring 3Cyberonics Provides Business Update on Depression Clinical Trial 2Cyberonics Provides Business Update on Depression Clinical Trial 3Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 2Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 3Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 4...is. -- The National Institute for General Medical ... SBIR Phase II grant, while the National Cancer In...ase I grant, the Madison-based company reported Th... be for the continued development, optimization an...sulfotransferases. , ,Sulfotransferase enzymes pla...
..., Wis. - Another dismal report on venture capital...wondering what the state must do to attract more p.... An interested observer in that debate could turn.... , ,The agenda for this week,s meeting of the inv...ension fund in the United States, includes a discu...
...ing companies are the "silent partners" of every o...a natural extension of your business. A bad one co...t part of doing business online is finding the rig...he server space, database and internet connectivit...cation, location, location ,From a customer,s per...
...Wis. -- Distance learning is about more than just...sroom, says Michael Schrage. Rather, technology is...what is taught, how it is taught, and what the rel... the information itself. , ,Schrage, a research as...b,s E-Markets Initiative, addressed the recent Dis...
Other Biology Technology:BellBrook Labs gets major research funding 2State investment board keeps an eye on Wisconsin's tech trends 2State investment board keeps an eye on Wisconsin's tech trends 3Silent partners: Selecting a web hosting company 2Silent partners: Selecting a web hosting company 3Silent partners: Selecting a web hosting company 4Schrage: Don't think of distance learning as just automation 2Schrage: Don't think of distance learning as just automation 3Tube-O-DIALYZER Floats, small.
Feline Rhinotracheitis Virus
Ezrin/Radixin/Moesin Antibody
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392
Biology Products: